Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances
L Zhao, S Jin, S Wang, Z Zhang, X Wang… - … and Targeted Therapy, 2024 - nature.com
Tertiary lymphoid structures (TLSs) are defined as lymphoid aggregates formed in non-
hematopoietic organs under pathological conditions. Similar to secondary lymphoid organs …
hematopoietic organs under pathological conditions. Similar to secondary lymphoid organs …
Trophoblast Side-Population Markers are Dysregulated in Preeclampsia and Fetal Growth Restriction
GP Wong, S Hartmann, DG Simmons, S Ellis… - Stem Cell Reviews and …, 2024 - Springer
Dysregulated progenitor cell populations may contribute to poor placental development and
placental insufficiency pathogenesis. Side-population cells possess progenitor properties …
placental insufficiency pathogenesis. Side-population cells possess progenitor properties …
[HTML][HTML] Immune cell topography of head and neck cancer
T Muijlwijk, DNLM Nijenhuis… - … for Immunotherapy of …, 2024 - ncbi.nlm.nih.gov
Background Approximately 50% of head and neck squamous cell carcinomas (HNSCC)
recur after treatment with curative intent. Immune checkpoint inhibitors are treatment options …
recur after treatment with curative intent. Immune checkpoint inhibitors are treatment options …
Multiplex Imaging for Cell Phenotyping of Early Human Atherosclerosis
M Elishaev, B Li, A Zhou, K Salim… - Journal of the …, 2024 - Am Heart Assoc
Background Previous studies using animal models and cultured cells suggest that vascular
smooth muscle cells (SMCs) and inflammatory cytokines are important players in …
smooth muscle cells (SMCs) and inflammatory cytokines are important players in …
Cellular and molecular events organizing the assembly of tertiary lymphoid structures in glioblastoma
A Vaccaro, F Yang, T van de Walle, S Franke… - bioRxiv, 2024 - biorxiv.org
Tertiary lymphoid structures (TLS) are ectopic lymphoid aggregates associated with
improved prognosis in numerous tumors. To date, their prognostic value in central nervous …
improved prognosis in numerous tumors. To date, their prognostic value in central nervous …
Immunostaging to Improve the Prediction of Relapse Risk in Stage III Melanoma
E Tavancheh - 2023 - opal.latrobe.edu.au
Immunostaging to Improve the Prediction of Relapse Risk in Stage III Melanoma Page 1
Immunostaging to Improve the Prediction of Relapse Risk in Stage III Melanoma Submitted by …
Immunostaging to Improve the Prediction of Relapse Risk in Stage III Melanoma Submitted by …